CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Sale | −2,300 | $61.59 | $142K | 45,772 |
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Sale | −1,300 | $62.43 | $81K | 44,472 |
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Sale | −115 | $63.40 | $7K | 44,357 |
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Sale | −3,533 | $60.55 | $214K | 40,824 |
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Sale | −3,650 | $61.59 | $225K | 37,174 |
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Sale | −1,891 | $62.48 | $118K | 35,283 |
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Sale | −123 | $63.69 | $8K | 35,160 |
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −6,250 | 0 | ||
| 2022-06-06 | Williams Kristen Marie Chief Administrative Officer | Sale | −3,969 | $61.37 | $244K | 18,299 |
| 2022-06-06 | SLONIN JONATHAN Chief Clinical Officer | Sale | −362 | $61.37 | $22K | 28,197 |
| 2022-06-06 | Riker Lauren Bullaro Senior Vice President, Finance | Sale | −1,150 | $61.37 | $71K | 14,002 |
| 2022-06-06 | Reinhart Charles A. III Chief Financial Officer | Sale | −2,516 | $61.37 | $154K | 28,283 |
| 2022-06-06 | REINHARDT MAX President, Rest of World | Sale | −2,817 | $61.37 | $173K | 26,833 |
| 2022-06-06 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Sale | −2,813 | $61.37 | $173K | 30,789 |
| 2022-06-06 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Sale | −2,980 | $61.37 | $183K | 14,570 |
| 2022-06-06 | McLoughlin Dennis Chief Customer Officer | Sale | −2,140 | $61.37 | $131K | 31,820 |
| 2022-06-06 | GAUGLER DARYL Chief Operating Officer | Sale | −1,106 | $61.37 | $68K | 11,494 |
| 2022-05-23 | SLONIN JONATHAN Chief Clinical Officer | Option exercise | +2,000 | $52.37 | $105K | 28,559 |
| 2022-05-23 | SLONIN JONATHAN Chief Clinical Officer | Option exercise · Stock Option (Right to Buy) | −2,000 | 35,500 | ||
| 2022-05-09 | Froimson Mark Director | Sale | −1,000 | $59.37 | $59K | 4,908 |
Page 16 of 23 · 450 trades